Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISE-1: RGN-259 for Dry Eye
NCT02597803Phase 3Completed
- Sponsor
- ReGenTree
- Start
- Sep 2015
- Primary completion
- Jun 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of timbetasin in dry eye syndrome (DED), sponsored by ReGenTree. Started Sep 2015; status: completed.
02
Drugs
timbetasin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02597803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597803.